News

Stride introduces ID gum

BY Allison Cerra

NEW YORK — Stride gum is inviting teenage consumers to embrace their individuality with the launch of new ID gum.

The core of the ID gum brand focuses on the teen experience, believing it’s better to explore individuality by staying open-minded rather than define themselves with a single identity, parent company Kraft Foods said. The gum is packaged in a sleek, innovative folding pack that features a magnetic closure. Once unwrapped, the pack reveals original artwork sourced from young emerging artists from around the world (there are 18 designs in total).

"Today’s teens are really looking for that emotional connection with their brands and are hungry for new ways to explore and display their creativity and individuality," said Stephanie Wilkes, Vice president of North America confections at Kraft Foods. "The uniqueness of ID gum — from the artwork to the packaging to its online gaming experience — takes discovery and personal expression to a whole new level."

ID gum, which began shipping to retailers nationwide in August, carries a suggested retail price of $1.49 per single pack and $3.29 for the multi-pack. The line currently is available in peppermint, berry melon and spearmint varieties.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

Retailers charge that proposed Visa/MasterCard interchange settlement is unacceptable

BY Michael Johnsen

ARLINGTON, Va. — Retailers are up in arms over the proposed settlement filed in July of antitrust lawsuits filed by merchants against Visa, MasterCard and the nation’s largest banks. A total of nine associations representing a broad swath of retail industry expressed their reservations to members of Congress on Thursday, charging that their interests were not represented and asking Congress to reject that settlement. 

“The proposed settlement, which was negotiated by Visa, MasterCard and lawyers purporting to represent the merchant community, is one-sided and preserves the very anticompetitive actions that were the genesis of the lawsuits," the collective associations suggested. "Quite simply, the proposed settlement is a bad deal for merchants and their customers. While the card networks and their representatives have suggested it is a fait accompli, the growing objections from the merchant community foreshadow the fight that lies ahead as Visa and MasterCard attempt to force the terms of the settlement on nearly 8 million merchants.” 

“Given the important oversight role of Congress and your continued interest in this important issue, we write today to urge you to reject the false claims from the card networks and their representatives. The proposed settlement does nothing to resolve the failures in the electronic payment market and continued Congressional involvement in these issues is imperative. We look forward to keeping you fully informed as the legal process moves forward and the chorus of objections grows,” the letter closed.

The letter was signed by the National Association of College Stores, the National Association of Convenience Stores, the National Association of Truck Stop Operators, the National Community Pharmacists Association, the National Cooperative Grocers Association, the National Grocers Association, the National Retail Federation, the Retail Industry Leaders Association and the Society of Independent Gasoline Marketers of America.

 

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

Sanofi, TB Alliance to collaborate on tuberculosis drugs

BY Alaric DeArment

NEW YORK — French drug maker Sanofi announced a deal with the Global Alliance for TB Drug Development to develop drugs for tuberculosis.

The drug maker and the TB Alliance said the deal will include discovery and development of new drug compounds for the disease, which caused almost 1.5 million deaths globally and affected nearly 9 million in 2010, according to the World Health Organization.

Under the agreement, the two will work on several new compounds in Sanofi’s library that have shown effectiveness against the bacterium that causes TB, known as Mycobacterium tuberculosis. This will include in-depth research of lead compounds and the chemical optimization of compounds that have been identified as hits through high-throughput screening. 


Interested in this topic? Sign up for our weekly Collaborative Care e-newsletter.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES